PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VHCAX vs. BIOPX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


VHCAXBIOPX
YTD Return15.75%36.45%
1Y Return23.59%46.50%
3Y Return (Ann)5.39%-1.16%
5Y Return (Ann)13.15%15.59%
10Y Return (Ann)12.70%9.82%
Sharpe Ratio1.622.22
Sortino Ratio2.292.85
Omega Ratio1.301.40
Calmar Ratio1.921.32
Martin Ratio7.7712.18
Ulcer Index3.05%3.81%
Daily Std Dev14.64%20.86%
Max Drawdown-54.27%-67.79%
Current Drawdown-2.74%-4.90%

Correlation

-0.50.00.51.00.9

The correlation between VHCAX and BIOPX is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

VHCAX vs. BIOPX - Performance Comparison

In the year-to-date period, VHCAX achieves a 15.75% return, which is significantly lower than BIOPX's 36.45% return. Over the past 10 years, VHCAX has outperformed BIOPX with an annualized return of 12.70%, while BIOPX has yielded a comparatively lower 9.82% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
5.71%
21.50%
VHCAX
BIOPX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


VHCAX vs. BIOPX - Expense Ratio Comparison

VHCAX has a 0.36% expense ratio, which is lower than BIOPX's 1.31% expense ratio.


BIOPX
Baron Opportunity Fund
Expense ratio chart for BIOPX: current value at 1.31% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.31%
Expense ratio chart for VHCAX: current value at 0.36% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.36%

Risk-Adjusted Performance

VHCAX vs. BIOPX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard Capital Opportunity Fund Admiral Shares (VHCAX) and Baron Opportunity Fund (BIOPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VHCAX
Sharpe ratio
The chart of Sharpe ratio for VHCAX, currently valued at 1.62, compared to the broader market0.002.004.001.62
Sortino ratio
The chart of Sortino ratio for VHCAX, currently valued at 2.29, compared to the broader market0.005.0010.002.29
Omega ratio
The chart of Omega ratio for VHCAX, currently valued at 1.30, compared to the broader market1.002.003.004.001.30
Calmar ratio
The chart of Calmar ratio for VHCAX, currently valued at 1.92, compared to the broader market0.005.0010.0015.0020.0025.001.92
Martin ratio
The chart of Martin ratio for VHCAX, currently valued at 7.77, compared to the broader market0.0020.0040.0060.0080.00100.007.77
BIOPX
Sharpe ratio
The chart of Sharpe ratio for BIOPX, currently valued at 2.22, compared to the broader market0.002.004.002.22
Sortino ratio
The chart of Sortino ratio for BIOPX, currently valued at 2.85, compared to the broader market0.005.0010.002.85
Omega ratio
The chart of Omega ratio for BIOPX, currently valued at 1.40, compared to the broader market1.002.003.004.001.40
Calmar ratio
The chart of Calmar ratio for BIOPX, currently valued at 1.32, compared to the broader market0.005.0010.0015.0020.0025.001.32
Martin ratio
The chart of Martin ratio for BIOPX, currently valued at 12.18, compared to the broader market0.0020.0040.0060.0080.00100.0012.18

VHCAX vs. BIOPX - Sharpe Ratio Comparison

The current VHCAX Sharpe Ratio is 1.62, which is comparable to the BIOPX Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of VHCAX and BIOPX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
1.62
2.22
VHCAX
BIOPX

Dividends

VHCAX vs. BIOPX - Dividend Comparison

VHCAX's dividend yield for the trailing twelve months is around 0.66%, while BIOPX has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
VHCAX
Vanguard Capital Opportunity Fund Admiral Shares
0.66%0.76%0.88%0.45%0.52%0.81%0.94%0.67%0.77%0.67%0.67%0.24%
BIOPX
Baron Opportunity Fund
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

VHCAX vs. BIOPX - Drawdown Comparison

The maximum VHCAX drawdown since its inception was -54.27%, smaller than the maximum BIOPX drawdown of -67.79%. Use the drawdown chart below to compare losses from any high point for VHCAX and BIOPX. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-2.74%
-4.90%
VHCAX
BIOPX

Volatility

VHCAX vs. BIOPX - Volatility Comparison

The current volatility for Vanguard Capital Opportunity Fund Admiral Shares (VHCAX) is 4.36%, while Baron Opportunity Fund (BIOPX) has a volatility of 5.78%. This indicates that VHCAX experiences smaller price fluctuations and is considered to be less risky than BIOPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%JuneJulyAugustSeptemberOctoberNovember
4.36%
5.78%
VHCAX
BIOPX